Lipid-lowering effect of berberine in human subjects and rats

Phytomedicine

Volumn 19, Issue 10, 2012, Pages 861-867

  Hu, Yueshan ^a,b   Ehli, Erik A ^a,b   Kittelsrud, Julie ^c   Ronan, Patrick J ^b,c   Munger, Karen ^c   Downey, Terry ^c   Bohlen, Krista ^a,c   Callahan, Leah ^c   Munson, Vicki ^c   Jahnke, Mike ^c   Marshall, Lindsey L ^d   Nelson, Kelly ^a   Huizenga, Patricia ^a   Hansen, Ryan ^a,c   Soundy, Timothy J ^b   Davies, Gareth E ^a,b,d  

^a Avera Health   (United States)

^b UNIVERSITY OF SOUTH DAKOTA   (United States)

^c Avera Research Institute   (United States)

^d SOUTH DAKOTA STATE UNIVERSITY   (United States)

Author keywords

Berberine; Human; Hyperlipidemia; Obesity; Osteoporosis; Pilot study; Rat

Indexed keywords

ANTILIPEMIC AGENT; ANTIOBESITY AGENT; BERBERINE; C REACTIVE PROTEIN; CALCITRIOL; CHOLESTEROL; CORTICOTROPIN; CYCLOOXYGENASE 2; HYDROCORTISONE; INTERLEUKIN 6; THYROTROPIN; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD CELL COUNT; BODY WEIGHT; CAUCASIAN; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DRUG ACTIVITY; DRUG EFFICACY; DRUG SAFETY; ELECTROCARDIOGRAPHY; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HORMONE BLOOD LEVEL; HUMAN; LIPID BLOOD LEVEL; MALE; METABOLISM; NONHUMAN; OBESITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; TREATMENT DURATION; TRIACYLGLYCEROL BLOOD LEVEL; WEIGHT REDUCTION;

ADULT; ANIMALS; BERBERINE; CALCITRIOL; CHOLESTEROL; COPTIS; DRUGS, CHINESE HERBAL; FEMALE; HUMANS; HYPERLIPIDEMIAS; HYPOLIPIDEMIC AGENTS; MALE; OBESITY; PHYTOTHERAPY; RATS, SPRAGUE-DAWLEY; TRIGLYCERIDES; WEIGHT LOSS;

RATTUS;

EID: 84864396863     PISSN: 09447113     EISSN: 1618095X     Source Type: Journal    
DOI: 10.1016/j.phymed.2012.05.009     Document Type: Article

References (31)

1. F. Affuso, V. Mercurio, V. Fazio, and S. Fazio Cardiovascular and metabolic effects of berberine World Journal of Cardiology 2 2010 71 77
2. J.A. Batch, and L.A. Baur 3. Management and prevention of obesity and its complications in children and adolescents Medical Journal of Australia 182 2005 130 135 (Pubitemid 40268259)
3. J.E. Blundell Serotonin and appetite Neuropharmacology 23 1984 1537 1551 (Pubitemid 15152980)
4. L.M. Browning, J.D. Krebs, E.C. Magee, G. Fruhbeck, and S.A. Jebb Circulating markers of inflammation and their link to indices of adiposity Obesity Facts 1 2008 259 265
5. F.L. Chen, Z.H. Yang, Y. Liu, L.X. Li, W.C. Liang, X.C. Wang, W.B. Zhou, Y.H. Yang, and R.M. Hu Berberine inhibits the expression of TNFalpha MCP-1, and IL-6 in AcLDL-stimulated macrophages through PPARgamma pathway Endocrine 33 2008 331 337
6. B.H. Choi, I.S. Ahn, Y.H. Kim, J.W. Park, S.Y. Lee, C.K. Hyun, and M.S. Do Berberine reduces the expression of adipogenic enzymes and inflammatory molecules of 3T3-L1 adipocyte Experimental and Molecular Medicine 38 2006 599 605
7. A.F. Cicero, L.C. Rovati, and I. Setnikar Eulipidemic effects of berberine administered alone or in combination with other natural cholesterol-lowering agents. A single-blind clinical investigation Arzneimittel-Forschung 57 2007 26 30 (Pubitemid 46212985)
8. E. Dalmas, C. Rouault, M. Abdennour, C. Rovere, S. Rizkalla, A. Bar-Hen, J.L. Nahon, J.L. Bouillot, M. Guerre-Millo, K. Clement, and C. Poitou Variations in circulating inflammatory factors are related to changes in calorie and carbohydrate intakes early in the course of surgery-induced weight reduction American Journal of Clinical Nutrition 94 2011 450 458
9. C.S. Elangbam Current strategies in the development of anti-obesity drugs and their safety concerns Veterinary Pathology 46 2009 10 24 (Review paper)
10. Y. Hu, and G.E. Davies Berberine increases expression of GATA-2 and GATA-3 during inhibition of adipocyte differentiation Phytomedicine 16 2009 864 873
11. Y. Hu, and G.E. Davies Berberine inhibits adipogenesis in high-fat diet-induced obesity mice Fitoterapia 81 2010 358 366
12. Y. Hu, H. Fahmy, J.K. Zjawiony, and G.E. Davies Inhibitory effect and transcriptional impact of berberine and evodiamine on human white preadipocyte differentiation Fitoterapia 81 2010 259 268
13. Y. Hu, E.A. Ehli, J.J. Hudziak, and G.E. Davies Berberine and evodiamine influence serotonin transporter (5-HTT) expression via the 5-HTT-linked polymorphic region Pharmacogenomics Journal 2011 10.1038/tpj.2011.24 [Epub ahead of print]
14. L.L. Ioannides-Demos, L. Piccenna, and J.J. McNeil Pharmacotherapies for obesity: past, current, and future therapies Journal of Obesity 2011 2011 179674
15. H.W. Jeong, K.C. Hsu, J.W. Lee, M. Ham, J.Y. Huh, H.J. Shin, W.S. Kim, and J.B. Kim Berberine suppresses proinflammatory responses through AMPK activation in macrophages American Journal of Physiology-Endocrinology and Metabolism 296 2009 E955 E964
16. W.J. Kong, J. Wei, Z.Y. Zuo, Y.M. Wang, D.Q. Song, X.F. You, L.X. Zhao, H.N. Pan, and J.D. Jiang Combination of simvastatin with berberine improves the lipid-lowering efficacy Metabolism: Clinical and Experimental 57 2008 1029 1037 (Pubitemid 351978060)
17. J.J. Lamb, M.F. Holick, R.H. Lerman, V.R. Konda, D.M. Minich, A. Desai, T.C. Chen, M. Austin, J. Kornberg, J.L. Chang, A. Hsi, J.S. Bland, and M.L. Tripp Nutritional supplementation of hop rho iso-alpha acids, berberine, vitamin D, and vitamin K produces a favorable bone biomarker profile supporting healthy bone metabolism in postmenopausal women with metabolic syndrome Nutrition Research 31 2011 347 355
18. H. Li, T. Miyahara, Y. Tezuka, T. Namba, T. Suzuki, R. Dowaki, M. Watanabe, N. Nemoto, S. Tonami, H. Seto, and S. Kadota The effect of kampo formulae on bone resorption in vitro and in vivo. II. Detailed study of berberine Biological & Pharmaceutical Bulletin 22 1999 391 396 (Pubitemid 29219983)
19. S.D. Malnick, and H. Knobler The medical complications of obesity QJM 99 2006 565 579 (Pubitemid 44540533)
20. NIH Clinical guidelines on the identification evaluation, and treatment of overweight and obesity in adults - the evidence report. National Institutes of Health Obesity Research 6 Suppl. 2 1998 51S 209S
21. J.C. Pickup Inflammation and activated innate immunity in the pathogenesis of type 2 diabetes Diabetes Care 27 2004 813 823 (Pubitemid 38280558)
22. J.B. Seo, S.S. Choe, H.W. Jeong, S.W. Park, H.J. Shin, S.M. Choi, J.Y. Park, E.W. Choi, J.B. Kim, D.S. Seen, J.Y. Jeong, and T.G. Lee Anti-obesity effects of Lysimachia foenum-graecum characterized by decreased adipogenesis and regulated lipid metabolism Experimental and Molecular Medicine 43 2011 205 215
23. Y. Tan, M.A. Kamal, Z.Z. Wang, W. Xiao, J.P. Seale, and X. Qu Chinese herbal extracts (SK0506) as a potential candidate for the therapy of the metabolic syndrome Clinical Science (London) 120 2011 297 305
24. P.R. Vuddanda, S. Chakraborty, and S. Singh Berberine: a potential phytochemical with multispectrum therapeutic activities Expert Opinion on Investigational Drugs 19 2010 1297 1307
25. H.A. Weber, M.K. Zart, A.E. Hodges, H.M. Molloy, B.M. O'Brien, L.A. Moody, A.P. Clark, R.K. Harris, J.D. Overstreet, and C.S. Smith Chemical comparison of goldenseal (Hydrastis canadensis L.) root powder from three commercial suppliers Journal of Agricultural and Food Chemistry 51 2003 7352 7358
26. W. Xie, D. Gu, J. Li, K. Cui, and Y. Zhang Effects and action mechanisms of berberine and Rhizoma coptidis on gut microbes and obesity in high-fat diet-fed C57BL/6J mice PLoS ONE 6 2011 e24520
27. D. Xu, W. Yang, C. Zhou, Y. Liu, and B. Xu Preventive effects of berberine on glucocorticoid-induced osteoporosis in rats Planta Medica 76 2010 1809 1813
28. J. Yin, H. Xing, and J. Ye Efficacy of berberine in patients with type 2 diabetes mellitus Metabolism: Clinical and Experimental 57 2008 712 717 (Pubitemid 351608234)
29. W. Zha, G. Liang, J. Xiao, E.J. Studer, P.B. Hylemon, W.M. Pandak Jr., G. Wang, X. Li, and H. Zhou Berberine inhibits HIV protease inhibitor-induced inflammatory response by modulating ER stress signaling pathways in murine macrophages PLoS ONE 5 2010 e9069
30. H. Zhang, J. Wei, R. Xue, J.D. Wu, W. Zhao, Z.Z. Wang, S.K. Wang, Z.X. Zhou, D.Q. Song, Y.M. Wang, H.N. Pan, W.J. Kong, and J.D. Jiang Berberine lowers blood glucose in type 2 diabetes mellitus patients through increasing insulin receptor expression Metabolism: Clinical and Experimental 59 2010 285 292
31. Y. Zhang, X. Li, D. Zou, W. Liu, J. Yang, N. Zhu, L. Huo, M. Wang, J. Hong, P. Wu, G. Ren, and G. Ning Treatment of type 2 diabetes and dyslipidemia with the natural plant alkaloid berberine Journal of Clinical Endocrinology and Metabolism 93 2008 2559 2565 (Pubitemid 352008520)